Skip to main content

Table 2 Intra– and postoperative outcomes of matched cohort

From: Sugammadex is associated with shorter hospital length of stay after open lobectomy for lung cancer: a retrospective observational study

Variable

Pyridostigmine (n = 127)

Sugammadex (n = 127)

p value

Surgery time (min)

210.0 (180.0–255.0)

210.0 (180.0–252.0)

0.067

PCA

  

0.004

 Epidural

110 (86.6)

90 (70.9)

 

 Intravenous

17 (13.4)

37 (29.1)

 

LOS (days)

12.0 (9.5–16.5)

10.0 (8.0–15.0)

0.005

PACU stay (min)

65.0 (60.0–80.0)

60.0 (55.0–75.0)

0.290

Events in PACU

 Dyspnea

4 (3.1)

3 (2.4)

1.000

 HDI

7 (5.5)

4 (3.1)

0.538

Events in Ward

 Pyrexia

38 (29.9)

28 (22.0)

0.198

 Dyspnea

17 (13.4)

10 (7.9)

0.222

 Air leak > 5 days

27 (21.3)

26 (20.5)

1.000

 Atelectasis

38 (29.9)

23 (18.1)

0.040

 Pneumonia

9 (7.1)

6 (4.7)

0.594

 MV

3 (2.4)

2 (1.6)

1.000

 HDI

7 (5.5)

1 (0.8)

0.072

 ICU

5 (3.9)

2 (1.6)

0.443

  1. Data are presented as n (%), median (interquartile range)
  2. PCA Patient controlled analgesia, LOS Length of stay, PACU Post anesthesia care unit, HDI Hemodynamic instability, MV Mechanical ventilator use, ICU Intensive care unit admission